Home › Funds › Artia Global Partners LP › CMPX
Artia Global Partners LP position in CMPX
COMPASS THERAPEUTICS INC · Health Care
Artia Global Partners LP reported holding 383,200 shares of CMPX (COMPASS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$839K, representing 0.15% of its reported portfolio and ranking #42 among its reported holdings. Artia Global Partners LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's CMPX position evolved
Artia Global Partners LP first disclosed a stake in CMPX in Q2 2026 at 383,200 shares (US$839K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 383.20K | $839.21K | New |
About CMPX and 13F data
CMPX (COMPASS THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in CMPX — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$39.4M), ORBIMED ADVISORS LLC (US$33.3M), MONTANOVA CAPITAL, LLC (US$30.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CMPX
- TANG CAPITAL MANAGEMENT LLC 17.99M sh · $39.40M · Q2 2026
- ORBIMED ADVISORS LLC 15.22M sh · $33.33M · Q2 2026
- MONTANOVA CAPITAL, LLC 14.10M sh · $30.88M · Q2 2026
- Enavate Sciences GP, LLC 7.79M sh · $17.06M · Q2 2026
- Vivo Capital, LLC 7.76M sh · $16.99M · Q2 2026
- Palo Alto Investors LP 5.83M sh · $12.77M · Q2 2026
- Birchview Capital, LP 1.68M sh · $3.67M · Q2 2026
- Atle Fund Management AB 1.05M sh · $2.30M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held CMPX?
Artia Global Partners LP has disclosed CMPX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Artia Global Partners LP's current position in CMPX?
As of Q2 2026, Artia Global Partners LP holds 383.20K shares of CMPX (COMPASS THERAPEUTICS INC), valued at $839.21K, representing 0.15% of its reported portfolio and ranking #42.
Has Artia Global Partners LP been buying or selling CMPX?
In the latest 13F filing (Q2 2026), Artia Global Partners LP newly opened its position in CMPX.
Which other funds hold CMPX?
Other major institutional holders of CMPX include TANG CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, MONTANOVA CAPITAL, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.